PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

BACKGROUND: Loss of the tumor suppressor phosphatase and tensin homolog (PTEN) occurs frequently in prostate cancers. Preclinical evidence suggests that activation of PI3K/AKT signaling through loss of PTEN can result in resistance to hormonal treatment in prostate cancer. OBJECTIVE: To explore the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur Urol
Main Authors: Ferraldeschi, Roberta, Nava Rodrigues, Daniel, Riisnaes, Ruth, Miranda, Susana, Figueiredo, Ines, Rescigno, Pasquale, Ravi, Praful, Pezaro, Carmel, Omlin, Aurelius, Lorente, David, Zafeiriou, Zafeiris, Mateo, Joaquin, Altavilla, Amelia, Sideris, Spyridon, Bianchini, Diletta, Grist, Emily, Thway, Khin, Perez Lopez, Raquel, Tunariu, Nina, Parker, Chris, Dearnaley, David, Reid, Alison, Attard, Gerhardt, de Bono, Johann
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Science 2015
Teme:
Prostate Cancer
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4410287/
https://ncbi.nlm.nih.gov/pubmed/25454616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.10.027
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki